Determinants of costs and the length of stay in acute coronary syndromes: A real life analysis of more than 10 000 patients

Cardiovascular Drugs and Therapy

Volumn 21, Issue 5, 2007, Pages 389-398

  Bramkamp, Matthias ^a   Radovanovic, Dragana ^b   Erne, Paul ^c   Szucs, Thomas D ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Kantonsspital Lucerne ^*  (Switzerland)

Author keywords

Acute coronary syndromes; Cost analysis; Cost predictors; Diagnosis related groups

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HOSPITAL CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; RISK FACTORS; SWITZERLAND; THROMBOLYTIC THERAPY;

EID: 35349025519     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-007-6044-0     Document Type: Article

References (28)

1. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27:1610-9, Jul.
2. Schweizerische Eidgenossenschaft, Bundesamt für Statistik, Junker C. Todesursachenstatistik, Ursachen der Sterblichkeit 2001 und 2002. http://www.bfs.admin.ch/bfs/portal/de/index.html (June 2006).
3. Schweizerische Eidgenossenschaft, Bundesamt für Statistik, Perret A. Tabellen der Gesundheitsstatistik Medizinische Statistik 2004 Resultate (Standardtabellen) Neuchâtel 2006, http://www.bfs.admin.ch/bfs/portal/de/ index.html (June 2006).
4. Schweizerische Eidgenossenschaft, Bundesamt für Statistik, Gerber Y-A. Kosten und Finanzierung des Gesundheitswesens 2003 BFS Statistik der Schweiz Neuchâtel 2006. http://www.bfs.admin.ch/bfs/portal/de/index.html (June 2006).
5. Grech ED. ABC of interventional cardiology: percutaneous coronary intervention. II: the procedure. BMJ 2003;326:1137-40.
6. Matsui K, Polanczyk CA, Gaspoz JM, Theres H, Kleber FX, Sobashima A, et al. Management of patients with acute myocardial infarction at five academic medical centers: clinical characteristics, resource utilization, and outcome. J Investig Med 1999;47:134-40.
7. Levy E, Gabriel S, Dinet J. The comparative medical costs of atherothrombotic disease in European countries. Pharmacoeconomics 2003;21:651-9.
8. Schweizerische Eidgenossenschaft, Bundesamt für Statistik, Durchschnittlich angepasste Kosten pro Pflegetag im Akutbereich 1999-2003 gewichtet durch den Case Mix 2003 http://www.bfs.admin.ch/bfs/portal/de/index. html (June 2006).
9. UBS Quotes; http://wb1.ubs.com/cache/fin/pub/gvu/quotes/ markets_instruments/?locale=en_US (May 2006).
10. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV, Jr, Brindis RG, et al. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J 2006;152:641-7.
11. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105:310-5.
12. Radovanovic D, Erne P, Schilling J, Noseda G, Gutzwiller F. Association of dyslipidemia and concomitant risk factors with in-hospital mortality in acute coronary syndrome in Switzerland. HeartDrug 2005;5:131-139.
13. Erhardt L, Herlitz J, Bossaert L, Halinen M, Keltai M, Koster R, et al. Task force on the management of chest pain. Eur Heart J 2002;23:1153-76.
14. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-40.
15. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
16. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the european society of cardiology. Eur Heart J 2005;26:804-47.
17. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience of 250 patients. Am J Cardiol 1967;20:457-64.
18. Reed SD, Friedman JY, Gnanasakthy A, Schulman KA. Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial. Int J Technol Assess Health Care 2003;19:396-406.
19. Fassa AA, Urban P, Radovanovic D, Duvoisin N, Gaspoz JM, Stauffer JC, et al. Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart 2005;91:882-8.
20. Kauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, et al. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J 2006;151:206-12.
21. Gandjour A, Kleinschmit F, Lauterbach KW. European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001). Eur Heart J 2002;23:858-68.
22. Mark DB, Newby LK. Early hospital discharge after uncomplicated myocardial infarction: are further improvements possible? Eur Heart J 2003;24:1613-5.
23. Kaul P, Newby LK, Fu Y, Mark DB, Califf RM, Topol EJ, et al. International differences in evolution of early discharge after acute myocardial infarction. Lancet 2004;363:511-7.
24. Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC, Jr, Pollack CV, Jr, et al. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. Arch Intern Med 2006;166:806-11.
25. Bramkamp M, Dedes KJ, Szucs TD. Pharmacotherapy of acute coronary syndromes: medical economics with an emphasis on clopidogrel. Cardiovasc Drugs Ther 2005;19:291-9.
26. Newby LK, Hasselblad V, Armstrong PW, Van de Werf F, Mark DB, White HD, et al. Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. Eur Heart J 2003;24:182-9.
27. Newby LK, Eisenstein EL, Califf RM, Thompson TD, Nelson CL, Peterson ED, et al. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med 2000;342:749-55.
28. InEK gGmbH, German Refined-Diagnosis Related Groups, Definitionshandbuch G-DRG-Version 2007-Fassung vom 06.12.2006, http://www.g-drg.de/ (January 2007).